Cassir Nadim, Delacroix Robin, Gomez Carine, Secq Véronique, Reynaud-Gaubert Martine, Thomas Pascal-Alexandre, Papazian Laurent, Drancourt Michel
Aix Marseille Univ, URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, IHU Méditerranée Infection, Marseille APHM, Service de Pneumologie, Equipe de Transplantation pulmonaire APHM, Service d'Anatomo-Pathologie APHM, Service de Chirurgie Thoracique, Equipe de Transplantation pulmonaire APHM, Service de Réanimation Détresses Respiratoires et Infections Sévères, Hôpital Nord, Marseille, France.
Medicine (Baltimore). 2017 Mar;96(13):e6173. doi: 10.1097/MD.0000000000006173.
Solid organ transplant recipients, especially after lung transplantation, are at increased risk for Mycobacterium tuberculosis pulmonary tuberculosis due to lifelong immunosuppression.
A 41-year-old woman underwent a second bilateral lung transplantation that was complicated by fatal pulmonary tuberculosis.
Histological examination of a lung biopsy performed 6 weeks after retransplantation revealed a caseating granuloma and necrosis. Acid-fast bacilli were identified as rifampicin-susceptible M. tuberculosis by real-time polymerase chain reaction (PCR), confirmed by culture 2 weeks later.
Our investigation led us to highly suspect that the transplanted lungs were the source of M. tuberculosis transmission.
In order to optimize diagnosis and treatment for lung recipients with latent or active tuberculosis, regular assessment of lower respiratory samples for M. tuberculosis, particularly during the 12-month period posttransplant should be implemented. Regarding donor-derived transmission, screening donor grafts with latent tuberculosis by M. tuberculosis real-time PCR in lymphoid and adipose tissues is an option that should be considered.
实体器官移植受者,尤其是肺移植后,由于终身免疫抑制,发生结核分枝杆菌肺结核的风险增加。
一名41岁女性接受了第二次双侧肺移植,术后并发致命性肺结核。
再次移植6周后进行的肺活检组织学检查显示有干酪样肉芽肿和坏死。通过实时聚合酶链反应(PCR)鉴定抗酸杆菌为对利福平敏感的结核分枝杆菌,2周后培养结果证实。
我们的调查使我们高度怀疑移植的肺是结核分枝杆菌传播的源头。
为了优化对潜伏性或活动性肺结核肺移植受者的诊断和治疗,应定期对下呼吸道样本进行结核分枝杆菌检测,尤其是在移植后12个月内。关于供体源性传播,通过结核分枝杆菌实时PCR在淋巴组织和脂肪组织中筛查潜伏性结核的供体移植物是一个应考虑的选择。